Maintenance pharmacotherapy of atopic dermatitis
- Authors: Petrova I.V.1, Omarov N.N.2, Sargsyan M.S.2, Khamroeva S.A.2, Osmanova Z.S.2, Proshin S.N.2
-
Affiliations:
- City Hospital of Norilsk No 2, Ministry of Healthcare of Russian Federation
- St. Petersburg State Medical Pediatric University
- Issue: Vol 16, No 1 (2018)
- Pages: 60-63
- Section: Articles
- URL: https://journals.rcsi.science/RCF/article/view/8781
- DOI: https://doi.org/10.17816/RCF16160-63
- ID: 8781
Cite item
Full Text
Abstract
Abstract. Atopic dermatitis (AD) — multifactorial inflammatory disease of skin characterized by pruritus, chronic recurrent process and age-related features of localization and morphology of lesions. This is one of most spread disease of skin up to 40%, meeting in all countries, in both sexes, in different age groups.
The aim. Prevention of severe forms of AD and complications.
Methods. To estimate the degree of atopic dermatitis was used international scale SCORAD (Scoring of Atopic Dermatitis). Results and discussion. At present time the pathogenesis of atopic dermatitis is discussed in terms of heredity resulting in disturbance of skin barrier, deficiency of immune system. The later means the stimulation of Th2-cells resulting in hyperproduction of IgE, hypersensitivity to allergens and nonspecific stimulants, colonization by pathogenic microorganism such as Staphylococcus aureus, Malassezia furfur and so on. The imbalance of autonomous nerve system with increased production of inflammatory mediators is strongly considered in the pathogenesis of atopic dermatitis too.
Conclusion. Considering the multifactoriality of atopic dermatitis the maintenance pharmacotherapy is of particular importance.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Inna V. Petrova
City Hospital of Norilsk No 2, Ministry of Healthcare of Russian Federation
Author for correspondence.
Email: doctorinna07@mail.ru
dermatologist, the Head of Division of Dermatology and Venereology
Russian Federation, NorilskNajmudin N. Omarov
St. Petersburg State Medical Pediatric University
Email: onazhmudin@br.ru
6th year student of Medical faculty
Russian Federation, Saint PetersburgMisha S. Sargsyan
St. Petersburg State Medical Pediatric University
Email: sayera.khamroeva@yandex.ru
6th year student of Medical faculty
Russian Federation, Saint PetersburgSaiyora A. Khamroeva
St. Petersburg State Medical Pediatric University
Email: sayera.khamroeva@yandex.ru
6th year student of Medical faculty
Russian Federation, Saint PetersburgZarema S. Osmanova
St. Petersburg State Medical Pediatric University
Email: zarema.osmanova.94@mail.ru
6th year student of Medical faculty
Russian Federation, Saint PetersburgSergei N. Proshin
St. Petersburg State Medical Pediatric University
Email: psnjsn@rambler.ru
Professor of the Department of Pharmacology, Clinical Pharmacology and Pharmacoeconomy
Russian Federation, Saint PetersburgReferences
- Кубанова А.А., Прошутинская Д.В., Текучева Л.В., Авди енко И.Н. Интегральный подход к наружной терапии атопического дерматита // Вестник дерматологии и венерологии. – 2010. – № 1. – С. – 20–26. [Kubanova AA, Proshutinskaya DV, Tekucheva LV, Avdienko IN. Integral approach to the external therapy of atopic dermatitis. Vestn Dermatol Venerol. 2010;(1):20-26. (In Russ.)]
- Danby SG. Staphylococcus aureus in atopic dermatitis: a diverse problem? Br J Dermatol. 2017;177(5):1164. doi: 10.1111/bjd.15942.
- Darsow U, Wollenberg A, Simon D, et al. Difficult to control atopic dermatitis. World Allergy Organ J. 2013;6(1):6. doi: 10.1186/1939-4551-6-6.
- Devillers AC, Oranje AP. Efficacy and safety of ‘wet-wrap’ dressings as an intervention treatment in children with severe and/or refractory atopic dermatitis: a critical review of the literature. Br J Dermatol. 2006;154(4):579-585. doi: 10.1111/j.1365-2133.2006.07157.x.
- Katayama I, Kohno Y, Akiyama K, et al. Japanese Guideline for Atopic Dermatitis 2014. Allergol Int. 2014;63(3):377-398. doi: 10.2332/allergolint.14-RAI-0769.
- Le Roux-Villet C, Prost-Squarcioni C, Oro S, et al. Role of the nurse in care of bullous pemphigoid. Revue de l’infirmiere. 2010(160):38-40.
- Reitamo S, Remitz A. An update on current pharmacotherapy options in atopic dermatitis. Expert Opin Pharmacother. 2014;15(11):1517-1524. doi: 10.1517/14656566.2014.915941.
- Schnopp C, Holtmann C, Stock S, et al. Topical steroids under wet-wrap dressings in atopic dermatitis – a vehicle-controlled trial. Dermatology. 2002;204(1):56-59. doi: 10.1159/000051811.
- Tang TS, Bieber T, Williams HC. Are the concepts of induction of remission and treatment of subclinical inflammation in atopic dermatitis clinically useful? J Allergy Clin Immunol. 2014;133(6):1615-1625.e1. doi: 10.1016/j.jaci.2013.12.1079.
